197 related articles for article (PubMed ID: 28008276)
1. Non-secretory multiple myeloma: from biology to clinical management.
Dupuis MM; Tuchman SA
Onco Targets Ther; 2016; 9():7583-7590. PubMed ID: 28008276
[TBL] [Abstract][Full Text] [Related]
2. Outcome and characteristics of nonsecretory multiple myeloma compared with secretory multiple myeloma: a retrospective multicenter study from China.
Sun H; Liu A; Liu L; Wang W; Cai Z; Yan H; Chen L; Gao G; Wang F; Liao A; Chen B; Feng J; Li J; Huang DP; Gao D; Zhang QK; Luo J; Fu R; Du J; Lu J
BMC Cancer; 2023 Oct; 23(1):930. PubMed ID: 37784037
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy.
Nandakumar B; Kumar SK; Dispenzieri A; Buadi FK; Dingli D; Lacy MQ; Hayman SR; Kapoor P; Leung N; Fonder A; Hobbs M; Hwa YL; Muchtar E; Warsame R; Kourelis TV; Russell S; Lust JA; Lin Y; Go RS; Siddiqui M; Zeldenrust S; Kyle RA; Gertz MA; Rajkumar SV; Gonsalves WI
Clin Lymphoma Myeloma Leuk; 2020 Jan; 20(1):53-56. PubMed ID: 31685378
[TBL] [Abstract][Full Text] [Related]
4. Nonsecretory Multiple Myeloma and AL Amyloidosis Presenting with Nephrotic Range Proteinuria.
Beyler Kilic O; Oguz AK; Ergun I; Baydar DE; Ayli M
Case Rep Nephrol; 2015; 2015():635974. PubMed ID: 26090243
[TBL] [Abstract][Full Text] [Related]
5. Calorimetric markers of Bence Jones and nonsecretory multiple myeloma serum proteome.
Todinova S; Krumova S; Radoeva R; Gartcheva L; Taneva SG
Anal Chem; 2014 Dec; 86(24):12355-61. PubMed ID: 25478781
[TBL] [Abstract][Full Text] [Related]
6. Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition.
Masood A; Christ T; Asif S; Rajakumar P; Gustafson BA; Shune LO; Salahudeen A; Nedvad D; Nanua S; Paner A; Kuzel TM; Levy M; Subramanian J; Raza S
NPJ Genom Med; 2021 Mar; 6(1):23. PubMed ID: 33731690
[TBL] [Abstract][Full Text] [Related]
7. Isolated Non-Secretory Extramedullary Relapse of Multiple Myeloma Responded Completely to Localized Radiotherapy.
Dawd D; Kapur S; Kotchetkov R
Case Rep Oncol; 2024; 17(1):423-429. PubMed ID: 38444889
[TBL] [Abstract][Full Text] [Related]
8. Atypical imaging feature of non-secretory multiple myeloma.
Neeravari A; Netravati P; Mohammed R; Ragupathi AR; Nagarajappa AH
Ann Diagn Pathol; 2011 Aug; 15(4):268-72. PubMed ID: 21546295
[TBL] [Abstract][Full Text] [Related]
9. A Case Report of Non-secretory Multiple Myeloma.
Kelley MA; Mestre A; Ayau MF; Arora A; Khillan R
Cureus; 2022 Sep; 14(9):e29571. PubMed ID: 36312670
[TBL] [Abstract][Full Text] [Related]
10. [Detection of serum free light chain and its clinical significance in nonsecretory multiple myeloma].
Chen HF; Hou J; Yuan ZG; Wang DX; Fu WJ; Chen YB
Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):113-6. PubMed ID: 18681313
[TBL] [Abstract][Full Text] [Related]
11. Rare incidence of non-secretory myeloma with talaromycosis: a case report.
Qin H; Qiu Y; Huang Y; Pan M; Lan D; Zeng W; Zhang J
BMC Infect Dis; 2021 Sep; 21(1):964. PubMed ID: 34530743
[TBL] [Abstract][Full Text] [Related]
12. Case of non-secretory multiple myeloma eventually diagnosed by
Haratake D; Kanno K; Ichinohe T; Ito M
Clin Case Rep; 2022 Jun; 10(6):e05628. PubMed ID: 35707676
[TBL] [Abstract][Full Text] [Related]
13. Case report: amyloid tumors in a case of non-secretory multiple myeloma.
Richter S; Makovitzky J
Acta Histochem; 2006; 108(3):221-6. PubMed ID: 16714048
[TBL] [Abstract][Full Text] [Related]
14. Non Secretory Multiple Myeloma With Extensive Extramedullary Plasmacytoma: A Diagnostic Dilemma.
Low SF; Mohd Tap NH; Kew TY; Ngiu CS; Sridharan R
Iran J Radiol; 2015 Jul; 12(3):e11760. PubMed ID: 26528383
[TBL] [Abstract][Full Text] [Related]
15. Case report. Non-secretory multiple myeloma presenting with diffuse sclerosis of affected bones interspersed with osteolytic lesions.
Prasad R; Yadav RR; Singh A; Mathur SP; Mangal Y; Singh M
Br J Radiol; 2009 Feb; 82(974):e29-31. PubMed ID: 19168686
[TBL] [Abstract][Full Text] [Related]
16. Non-secretory multiple myeloma with diagnostic challenges.
Hamidah NH; Azma RZ; Ezalia E; Das S; Umar NA; Swaminathan M; Mohamed Z; Abdul Wahid SF
Clin Ter; 2010; 161(5):445-8. PubMed ID: 20949241
[TBL] [Abstract][Full Text] [Related]
17. Reference change values of M-protein, free light chain and immunoglobulins in monoclonal gammopathy.
Evliyaoglu O; van Helden J; Jaruschewski S; Imöhl M; Weiskirchen R
Clin Biochem; 2019 Dec; 74():42-46. PubMed ID: 31526775
[TBL] [Abstract][Full Text] [Related]
18. Non-Secretory Myeloma: Ready for a new Definition?
Corso A; Mangiacavalli S
Mediterr J Hematol Infect Dis; 2017; 9(1):e2017053. PubMed ID: 28894562
[TBL] [Abstract][Full Text] [Related]
19. The evolving use of serum free light chain assays in haematology.
Pratt G
Br J Haematol; 2008 May; 141(4):413-22. PubMed ID: 18318757
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA
Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
